VINCIARELLI PATRIZIO sold $6.6M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $330.56 ($322.74–$342.51, $6.61M total) across 15 trades on 2026-06-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 29, 2026, 2:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 3:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure provides a concrete, time-stamped insider selling datapoint (size, price range, and post-transaction holdings) but no accompanying fundamental catalyst.

02

Market read

Traders may monitor for follow-on insider activity or interpret the sale as routine 10b5-1 liquidity; absent other news, impact is likely modest.

03

What to watch

The article does not state whether the insider’s remaining stake is changing materially over time, nor does it provide context on prior 10b5-1 sales cadence.

Relevance 5/10Novelty 6/10Timing: today’s SEC Form 4 filing (filed 2026-06-29)

Background

The article is an SEC Form 4 insider transaction: CEO/Chairman VINCIARELLI PATRIZIO sold 20,000 VICR shares across 15 trades on 2026-06-25 under a 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold about $6.61M of shares via a pre-arranged 10b5-1 plan, with weighted-average sale price ~$330.56.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a Form 4 primary disclosure with sale size and pricing, but it does not include new operating, guidance, or regulatory information.

Market effects

No sector read-across is provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the signal may be overstated; traders may treat it as routine liquidity rather than bearish information.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale; CEO/Chairman sold shares under a 10b5-1 plan.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.